OCRX
Ocera Therapeutics, Inc.
OCRX
OCRX
Delisted
OCRX was delisted on the 8th of December, 2017.
33 hedge funds and large institutions have $22.7M invested in Ocera Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
33
Holding in Top 10
1
Calls
$114K
Puts
–
Top Buyers
| 1 | +$2.79M | |
| 2 | +$273K | |
| 3 | +$221K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$155K |
| 5 |
Renaissance Technologies
New York
|
+$121K |
Top Sellers
| 1 | -$1.07M | |
| 2 | -$657K | |
| 3 | -$235K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$59K |
| 5 |
QSS
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
|
-$42K |